PH
71
-3
HPQ
37
2
BAX
50
-3
FRT
58
-2
TMO
50
-4
DLTR
64
-2
XEL
39
-2
EOG
32
-14
AEE
53
-5
SE
43
3
DVA
49
-3
UAL
82
3
NWL
58
-2
PM
60
-2
LB
22
-7
EL
58
5
PGR
55
-3
PEG
53
-2
NEM
64
-4
AES
51
-4
PH
71
-3
HPQ
37
2
BAX
50
-3
FRT
58
-2
TMO
50
-4
DLTR
64
-2
XEL
39
-2
EOG
32
-14
AEE
53
-5
SE
43
3
DVA
49
-3
UAL
82
3
NWL
58
-2
PM
60
-2
LB
22
-7
EL
58
5
PGR
55
-3
PEG
53
-2
NEM
64
-4
AES
51
-4
Financhill
Back

Columbia Seligman Premium Technology Growth Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Buy
55

STK
Columbia Seligman Premium Technology Growth Fund

Last Price:
$34.88
Seasonality Move:
0.87%
Buy
64

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$86.42
Seasonality Move:
-30.03%
Buy
55
Columbia Seligman Premium Technology Growth Fund (STK) is a Buy

Is Columbia Seligman Premium Technology Growth Fund a Buy, Sell or Hold?

  • The current Columbia Seligman Premium Technology Growth Fund [STK] share price is $35.45. The Score for STK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • STK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

STK Stock Price Chart

What is Columbia Seligman Premium Technology Growth Fund's stock price today?

  • The Columbia Seligman Premium Technology Growth Fund share price today is $35.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STK is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $93.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

STK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 40.44 Sell
Chaikin Money Flow: 16137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 147064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

STK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.84 Sell
20-day SMA: 36.09 Sell
50-day SMA: 36.85 Sell
200-day SMA: 31.84 Buy
8-day EMA: 36.38 Sell
20-day EMA: 36.58 Sell
50-day EMA: 36.27 Sell
200-day EMA: 33.55 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.53 Buy
20-day SMA: 72.88 Buy
50-day SMA: 64.83 Buy
200-day SMA: 42.54 Buy
8-day EMA: 84.37 Buy
20-day EMA: 75.93 Buy
50-day EMA: 66.06 Buy
200-day EMA: 46.89 Buy

Columbia Seligman Premium Technology Growth Fund Earnings Growth & STK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Columbia Seligman Premium Technology Growth Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):